Firemní tisková prohlášení

02 čvc 2019

BC Partners to Acquire Synthon International Holding B.V.

read more
05 říj 2017

Regulatory Approval in Europe granted for Synthon’s glatiramer acetate 40 mg/ml

read more
13 zář 2017

European Patent Office decides in Synthon’s favor in glatiramer patent case

read more
12 dub 2016

Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe

read more
03 srp 2015

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

read more
28 dub 2015

Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

read more
09 říj 2014

Synthon Announces Filing of Glatiramer Acetate 40 mg/mL ANDA Containing a Paragraph IV Certification

read more
15 dub 2014

Synthon obtains European approvals for sevelamer

read more
27 bře 2014

Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate

read more
24 kvě 2012

Synthon obtains European approvals for zoledronic acid

read more
     Share this page